Little discovery in the laboratory: a new route for 56621-48-8

Compound(56621-48-8)Recommanded Product: 56621-48-8 received a lot of attention, and I have introduced some compounds in other articles, similar to this compound(4-(Piperazin-1-yl)phenol), if you are interested, you can check out my other related articles.

Heterocyclic compounds can be divided into two categories: alicyclic heterocycles and aromatic heterocycles. Compounds whose heterocycles in the molecular skeleton cannot reflect aromaticity are called alicyclic heterocyclic compounds. Compound: 56621-48-8, is researched, Molecular C10H14N2O, about Synthesis, anticancer activity and molecular docking studies of new 4-nitroimidazole derivatives, the main research direction is nitroimidazolylsulfanyl phenylpiperazinyl propanone preparation antitumor mol docking.Recommanded Product: 56621-48-8.

Herein, we report the synthesis of 3-(1-benzyl-2-ethyl-4-nitro-1H-imidazol-5-ylsulfanyl)-1-(4-substituted phenyl-piperazin-1-yl)-propan-1-one I [R = H, 2-F, 4-Cl, etc.] by reaction of 3-(1-benzyl-2-methyl-4-nitro-1H-imidazol-5-ylsulfanyl)-propanoyl chloride (3) with piperazine nucleophiles. Eighteen compounds were assessed for their antiproliferative inhibition potency against four human cancer cell lines (MCF-7, PC3, MDA MB231 and Du145). Compounds I [R = 2-Me, 2-OH]were the most potent anticancer agents on MCF-7 cell lines cell line with IC50 value of 1.0μg/mL, while I [R = 2-CN, 4-Cl] exhibited cytotoxic effect on PC3 and DU145 cell lines with IC50 values of 4.0 and 5.0μg/mL, resp. The mol. docking of compounds I [R = 2-Me, 2-CN, 4-Cl] was studied.

Compound(56621-48-8)Recommanded Product: 56621-48-8 received a lot of attention, and I have introduced some compounds in other articles, similar to this compound(4-(Piperazin-1-yl)phenol), if you are interested, you can check out my other related articles.

Reference:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem